Table 1 Characteristics of included studies
Study | Publication year | Country | Sample size(N) | Age (mean ± SD) | Male (N) | Sensitivity | 95%CI | Specificity | 95%CI |
|---|---|---|---|---|---|---|---|---|---|
Abdollahi et al. [18] | 2021 | Iran | 742 | 56.59 ± 14.88 | 451 (60.8%) | 0.63 | 0.54–0.71 | 0.53 | 0.48–0.58 |
Angeli et al. [15] | 2021 | Italy | 301 | 69.8 ± 13.0 | 209 (69.4%) | 0.38 | 0.29–0.47 | 0.92 | 0.87–0.96 |
Bayrak et al. [19] | 2021 | Turkey | 86 | 71.1 ± 14.1 | 61 (70.9%) | 0.42 | 0.28–0.58 | 0.77 | 0.56–0.91 |
Besutti et al. [20] | 2021 | Italy | 866 | 59.8 (50.2–72.5)* | 527 (60.85%) | 0.57 | 0.46–0.67 | 0.83 | 0.80–0.85 |
Charpentier et al. [21] | 2021 | France | 210 | 66 ± 16 | 146 (69.5%) | 0.75 | 0.60–0.86 | 0.64 | 0.56–0.71 |
Dilek et al. [22] | 2021 | Turkey | 100 | 61 ± 14.85 | 61 (61%) | 0.76 | 0.62–0.87 | 0.66 | 0.51–0.79 |
Guillo et al. [23] | 2020 | France | 214 | 59 ± 19 | 119 (56%) | 0.68 | 0.49–0.83 | 0.74 | 0.64–0.82 |
Hajiahmadi et al. [24] | 2021 | Iran | 192 | 57.5 ± 1.11 | 114(59.38%) | 0.67 | 0.49–0.81 | 0.73 | 0.65–0.80 |
Isik et al. [25] | 2021 | Turkey | 257 | 52 ± 14.62 | 142 (55.3%) | 0.74 | 0.49–0.91 | 0.65 | 0.59–0.71 |
Kazemi et al. [26] | 2020 | Iran | 91 | 58.04 ± 16.5 | 57 (62.6%) | 0.67 | 0.51–0.81 | 0.69 | 0.54–0.81 |
Kimura-Sandoval et al. [27] | 2021 | Mexico | 166 | 50 ± 14 | 100(60.2%) | 0.83 | 0.66–0.93 | 0.82 | 0.74–0.88 |
Li et al. [28] | 2021 | China | 147 | 66 (57–72)* | 83 (54%) | 0.50 | 0.29–0.71 | 0.90 | 0.84–0.95 |
Li et al. [29] | 2020 | China | 102 | 57 (45–70)* | 59 (58%) | 0.64 | 0.31–0.89 | 0.95 | 0.76–1.00 |
Li et al. [30] | 2020 | China | 83 | 45.5 ± 12.3 | 44 (53.0%) | 0.80 | 0.59–0.93 | 0.83 | 0.71–0.91 |
Li et al. [31] | 2020 | China | 46 | 71.1 ± 8.5 | 65 (66.3%) | 0.83 | 0.63–0.95 | 0.77 | 0.55–0.92 |
Magdy et al. [32] | 2021 | China | 266 | 34.75 ± 10.7 | 176(66.17%) | 1.00 | 0.69–1.00 | 0.92 | 0.85–0.98 |
Mirza-Aghazadeh-Attari et al. [33] | 2020 | Iran | 50 | 65.4 ± 16.77 | 27(54%) | 0.74 | 0.52–0.90 | 0.63 | 0.42–0.81 |
Raoufi et al. [34] | 2020 | Iran | 380 | 53.62 ± 16.66 | 251 (66.1%) | 0.76 | 0.56–0.90 | 0.76 | 0.71–0.80 |
Ruch et al. [35] | 2020 | France | 572 | 66.0 ± 16.0 | 343 (60.0%) | 0.32 | 0.26–0.39 | 0.92 | 0.89–0.95 |
Salahshour et al. [36] | 2020 | Iran | 739 | 49.2 ± 17.2 | 419(56.7%) | 0.64 | 0.44–0.81 | 0.87 | 0.83–0.90 |
Salvatore et al. [37] | 2021 | Italy | 103 | 61.0 (23.0–91.0)*** | 59 (60.20%) | 0.53 | 0.27–0.79 | 0.84 | 0.70–0.93 |
Tabatabaei et al. [38] | 2020 | Iran | 90 | 44.2 ± 5.9 and 44.3 ± 5.9 for non-survivors and survivors, respectively | 54(60%) | 0.83 | 0.65–0.94 | 0.87 | 0.75–0.94 |
Yuan et al. [13] | 2020 | China | 27 | 60 (47–69)* | 12(44.44%) | 0.86 | 0.42–1.00 | 0.82 | 0.57–0.96 |
Zhou et al. [39] | 2020 | China | 134 | 48 (38–61)* and 68 (59–76)* for survivors and non-survivors, respectively | 85(63.43%) | 0.69 | 0.57–0.80 | 0.82 | 0.70–0.91 |